Evidence map›Paper›PMID 40084888›Full record

ArticlemBio2025

Cell envelope polysaccharide modifications alter the surface properties and interactions of

Elena Lian, Juan M Belardinelli, Kavita De, Arun Prasad Pandurangan, Shiva K Angala, Zuzana Palčeková, Anna E Grzegorzewicz, Josephine M Bryant, Tom L Blundell, Julian Parkhill and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Leucine auxotrophic marker for genetic manipulation ofApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Mutations in theMicrobiology spectrum · 2026
    Article
  4. Journal of bacteriology · 2026
    Review
  5. Case Report: SuspectedFrontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elena LianMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.ORCID 0000-0003-3344-6407
Juan M BelardinelliMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.ORCID 0000-0003-1336-9141
Kavita DeMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Arun Prasad PanduranganVictor Phillip Dahdaleh Heart and Lung Research Institute, Trumpington, Cambridge, UK.
Shiva K AngalaMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Zuzana PalčekováMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Anna E GrzegorzewiczMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Josephine M BryantParasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
Tom L BlundellVictor Phillip Dahdaleh Heart and Lung Research Institute, Trumpington, Cambridge, UK.
Julian ParkhillDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7069-5958
R Andres FlotoCambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.
William H WheatMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Mary JacksonMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.ORCID 0000-0002-9212-0258

Funding

Assembly and export of mycobacterial lipoglycansR01AI155674 · NIAID · COLORADO STATE UNIVERSITY · PI JACKSON, MARY · 2021 to 2025
$3.0M
CSU Infectious Disease Research and Response Training ProgramT32AI162691 · NIAID · COLORADO STATE UNIVERSITY · PI DEAN, GREGG A · 2021 to 2025
$2.1M
Cystic Fibrosis Foundation JACKSO21-G0Cystic Fibrosis Trust SRC010National Institute of Allergy and Infectious Diseases AI155674National Institute of Allergy and Infectious Diseases T32AI162691NIAID NIH HHS R01 AI155674NIAID NIH HHS T32 AI162691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell WallImmunity, InnateMycobacterium abscessusBacterial ProteinsBiofilmsGalactansHumansLipopolysaccharidesMutationMycobacterium Infections, NontuberculousarabinogalactanBacterial ProteinsGalactanslipoarabinomannanLipopolysaccharidesarabinogalactanbiofilmimmunomodulationlipoarabinomannanmorphotypeMycobacterium abscessusnon-tuberculous mycobacteriavirulence

Identifiers

PMID40084888
PMCPMC11980365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.